Docosahexaenoyl ethanolamide improves glucose uptake and alters endocannabinoid system gene expression in proliferating and differentiating C2C12 myoblasts

Frontiers in Physiology

Volumn 5 MAR, Issue , 2014, Pages

  Kim, Jeffrey ^a   Carlson, Morgan E ^a   Watkins, Bruce A ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

C2C12 myoblasts; Cannabinoid receptors; DHEA; Endocannabinoid system; Gene expression; Glucose uptake; Polyunsaturated fatty acids

Indexed keywords

2 ARACHIDONOYLGLYCEROL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ADENYLATE CYCLASE; ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID 2 RECEPTOR; DOCOSAHEXAENOIC ACID; DOCOSAHEXAENOYLETHANOLAMIDE; ENDOCANNABINOID; GLUCOSE; MESSENGER RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRAIN C2C12; CONTROLLED STUDY; FATTY ACID ANALYSIS; FLOW CYTOMETRY; GENE EXPRESSION; GLUCOSE TRANSPORT; INFLAMMATION; MYOBLAST; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84897932330     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00100     Document Type: Article

References (61)

1. Artmann, A., Petersen, G., Hellgren, L. I., Boberg, J., Skonberg, C., Nellemann, C., et al. (2008). Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim. Biophys. Acta 1781, 200-212. doi: 10.1016/j.bbalip.2008.01.006.
2. Baron, A. D., Brechtel, G., Wallace, P., and Edelman, S. V. (1988). Rates and tissue sites of non-insulin-and insulin-mediated glucose uptake in humans. Am. J. Physiol. 255, E769-E774.
3. Batetta, B., Griinari, M., Carta, G., Murru, E., Ligresti, A., Cordeddu, L., et al. (2009). Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats. J. Nutr. 139, 1495-1501. doi: 10.3945/jn.109.104844.
4. Bennett, A. M., and Tonks, N. K. (1997). Regulation of distinct stages of skeletal muscle differentiation by mitogen-activated protein kinases. Science 278, 1288-1291. doi: 10.1126/science.278.5341.1288.
5. Best, J. D., Kahn, S. E., Ader, M., Watanabe, R. M., Ni, T. C., and Bergman, R. N. (1996). Role of glucose effectiveness in the determination of glucose tolerance. Diabetes Care 19, 1018-1030.
6. Bluher, M., Engeli, S., Kloting, N., Berndt, J., Fasshauer, M., Batkai, S., et al. (2006). Dysregulation of the peripheral and adipose tissue endocannabinoid system in human abdominal obesity. Diabetes 55, 3053-3060. doi: 10.2337/db06-0812.
7. Braun, T., Bober, E., Buschhausen-Denker, G., Kohtz, S., Grzeschik, K. H., and Arnold, H. H. (1989). Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the Myf gene products. EMBO J. 8, 3617-3625.
8. Brown, A. J., Pang, E., and Roberts, D. C. (1991). Persistent changes in the fatty acid composition of erythrocyte membranes after moderate intake of n-3 polyunsaturated fatty acids: study design implications. Am. J. Clin. Nutr. 54, 668-673.
9. Buhl, E. S., Jessen, N., Pold, R., Ledet, T., Flyvbjerg, A., Pedersen, S. B., et al. (2002). Long-term AICAR administration reduces metabolic disturbances and lowers blood pressure in rats displaying features of the insulin resistance syndrome. Diabetes 51, 2199-2206. doi: 10.2337/diabetes.51.7.2199.
10. Capaldo, B., Santoro, D., Riccardi, G., Perrotti, N., and Sacca, L. (1986). Direct evidence for a stimulatory effect of hyperglycemia per se on peripheral glucose disposal in type II diabetes. J. Clin. Invest. 77, 1285-1290. doi: 10.1172/JCI112432.
11. Cavuoto, P., McAinch, A. J., Hatzinikolas, G., Cameron-Smith, D., and Wittert, G. A. (2007). Effects of cannabinoid receptors on skeletal muscle oxidative pathways. Mol. Cell. Endocrinol. 267, 63-69. doi: 10.1016/j.mce.2006.12.038.
12. Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., et al. (2003). Endogenous cannabinoid system as a modulator of food intake. Int. J. Obes. Relat. Metab. Disord. 27, 289-301. doi: 10.1038/sj.ijo.0802250.
13. De Petrocellis, L., Melck, D., Bisogno, T., Milone, A., and Di Marzo, V. (1999). Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92, 377-387. doi: 10.1016/S0306-4522(98)00749-0.
14. Despres, J. P., Golay, A., and Sjostrom, L. (2005). Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N. Engl. J. Med. 353, 2121-2134. doi: 10.1056/NEJMoa044537.
15. Di Marzo, V., Goparaju, S. K., Wang, L., Liu, J., Batkai, S., Jarai, Z., et al. (2001). Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410, 822-825. doi: 10.1038/35071088.
16. Eckardt, K., Sell, H., Taube, A., Koenen, M., Platzbecker, B., Cramer, A., et al. (2009). Cannabinoid type 1 receptors in human skeletal muscle cells participate in the negative crosstalk between fat and muscle. Diabetologia 52, 664-674. doi: 10.1007/s00125-008-1240-4.
17. Edmondson, D. G., and Olson, E. N. (1989). A gene with homology to the myc similarity region of MyoD1 is expressed during myogenesis and is sufficient to activate the muscle differentiation program. Genes Dev. 3, 628-640. doi: 10.1101/gad.3.5.628.
18. Engeli, S., Bohnke, J., Feldpausch, M., Gorzelniak, K., Janke, J., Batkai, S., et al. (2005). Activation of the peripheral endocannabinoid system in human obesity. Diabetes 54, 2838-2843. doi: 10.2337/diabetes.54.10.2838.
19. Esposito, I., Proto, M. C., Gazzerro, P., Laezza, C., Miele, C., Alberobello, A. T., et al. (2008). The cannabinoid CB1 receptor antagonist rimonabant stimulates 2-deoxyglucose uptake in skeletal muscle cells by regulating the expression of phosphatidylinositol-3-kinase. Mol. Pharmacol. 74, 1678-1686. doi: 10.1124/mol.108.049205.
20. Felder, C. C., Briley, E. M., Axelrod, J., Simpson, J. T., Mackie, K., and Devane, W. A. (1993). Anandamide, an endogenous cannabimimetic eicosanoid, binds to the cloned human cannabinoid receptor and stimulates receptor-mediated signal transduction. Proc. Natl. Acad. Sci. U.S.A. 90, 7656-7660. doi: 10.1073/pnas.90.16.7656.
21. Fuchtbauer, E. M., and Westphal, H. (1992). MyoD and myogenin are coexpressed in regenerating skeletal muscle of the mouse. Dev. Dyn. 193, 34-39. doi: 10.1002/aja.1001930106.
22. Fujii, N., Hayashi, T., Hirshman, M. F., Smith, J. T., Habinowski, S. A., Kaijser, L., et al. (2000). Exercise induces isoform-specific increase in 5'AMP-activated protein kinase activity in human skeletal muscle. Biochem. Biophys. Res. Commun. 273, 1150-1155. doi: 10.1006/bbrc.2000.3073.
23. Gabler, N. K., Radcliffe, J. S., Spencer, J. D., Webel, D. M., and Spurlock, M. E. (2009). Feeding long-chain n-3 polyunsaturated fatty acids during gestation increases intestinal glucose absorption potentially via the acute activation of AMPK. J. Nutr. Biochem. 20, 17-25. doi: 10.1016/j.jnutbio.2007.11.009.
24. Garrington, T. P., and Johnson, G. L. (1999). Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 11, 211-218. doi: 10.1016/S0955-0674(99)80028-3.
25. Hasty, P., Bradley, A., Morris, J. H., Edmondson, D. G., Venuti, J. M., Olson, E. N., et al. (1993). Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 364, 501-506. doi: 10.1038/364501a0.
26. Holmes, B. F., Kurth-Kraczek, E. J., and Winder, W. W. (1999). Chronic activation of 5'-AMP-activated protein kinase increases GLUT-4, hexokinase, and glycogen in muscle. J. Appl. Physiol. (1985) 87, 1990-1995.
27. Howlett, A. C. (2005). Cannabinoid receptor signaling. Handb. Exp. Pharmacol. 53-79. doi: 10.1007/3-540-26573-2_2.
28. Hutchins-Wiese, H. L., Li, Y., Hannon, K., and Watkins, B. A. (2012). Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle. J. Nutr. Biochem. 23, 986-993. doi: 10.1016/j.jnutbio.2011.05.005.
29. Hutchins, H. L., Li, Y., Hannon, K., and Watkins, B. A. (2011). Eicosapentaenoic acid decreases expression of anandamide synthesis enzyme and cannabinoid receptor 2 in osteoblast-like cells. J. Nutr. Biochem. 22, 195-200. doi: 10.1016/j.jnutbio.2010.06.001.
30. Khurana, A., and Dey, C. S. (2004). Involvement of c-Jun N-terminal kinase activities in skeletal muscle differentiation. J. Muscle Res. Cell Motil. 25, 645-655. doi: 10.1007/s10974-004-7099-1.
31. Lee, J., Sun, C., Zhou, Y., Gokalp, D., Herrema, H., Park, S. W., et al. (2011). p38 MAPK-mediated regulation of Xbp1s is crucial for glucose homeostasis. Nat. Med. 17, 1251-1260. doi: 10.1038/nm.2449.
32. Lee, J. H., Tachibana, H., Morinaga, Y., Fujimura, Y., and Yamada, K. (2009). Modulation of proliferation and differentiation ofC2C12 skeletal muscle cells by fatty acids. Life Sci. 84, 415-420. doi: 10.1016/j.lfs.2009.01.004.
33. Lee, M. S., Kim, I. H., and Kim, Y. (2013). Effects of eicosapentaenoic acid and docosahexaenoic acid on uncoupling protein 3 gene expression in C(2)C(12) muscle cells. Nutrients 5, 1660-1671. doi: 10.3390/nu5051660.
34. Li, J., and Johnson, S. E. (2006). ERK2 is required for efficient terminal differentiation of skeletal myoblasts. Biochem. Biophys. Res. Commun. 345, 1425-1433. doi: 10.1016/j.bbrc.2006.05.051.
35. Li, Y., Greiner, R. S., Salem, N. Jr., and Watkins, B. A. (2003). Impact of dietary n-3 FA deficiency on rat bone tissue FA composition. Lipids 38, 683-686. doi: 10.1007/s11745-003-1115-8.
36. Li, Y., Seifert, M. F., Lim, S. Y., Salem, N. Jr., and Watkins, B. A. (2010). Bone mineral content is positively correlated to n-3 fatty acids in the femur of growing rats. Br. J. Nutr. 104, 674-685. doi: 10.1017/S0007114510001133.
37. Lipina, C., Stretton, C., Hastings, S., Hundal, J. S., Mackie, K., Irving, A. J., et al. (2010). Regulation of MAP Kinase-directed mitogenic and protein kinase B-mediated signaling by cannabinoid receptor type 1 in skeletal muscle cells. Diabetes 59, 375-385. doi: 10.2337/db09-0979.
38. Liu, Y. L., Connoley, I. P., Wilson, C. A., and Stock, M. J. (2005). Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lep(ob)/Lep(ob) mice. Int. J. Obes. (Lond.) 29, 183-187. doi: 10.1038/sj.ijo.0802847.
39. Lo, C. J., Chiu, K. C., Fu, M., Chu, A., and Helton, S. (2000). Fish oil modulates macrophage P44/P42 mitogen-activated protein kinase activity induced by lipopolysaccharide. J. Parenter. Enteral Nutr. 24, 159-163. doi: 10.1177/0148607100024003159.
40. Matias, I., Carta, G., Murru, E., Petrosino, S., Banni, S., and Di Marzo, V. (2008). Effect of polyunsaturated fatty acids on endocannabinoid and N-acyl-ethanolamine levels in mouse adipocytes. Biochim. Biophys. Acta 1781, 52-60. doi: 10.1016/j.bbalip.2007.11.001.
41. Matias, I., Gonthier, M. P., Orlando, P., Martiadis, V., De Petrocellis, L., Cervino, C., et al. (2006). Regulation, function, and dysregulation of endocannabinoids in models of adipose and beta-pancreatic cells and in obesity and hyperglycemia. J. Clin. Endocrinol. Metab. 91, 3171-3180. doi: 10.1210/jc.2005-2679.
42. Nabeshima, Y., Hanaoka, K., Hayasaka, M., Esumi, E., Li, S., and Nonaka, I. (1993). Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 364, 532-535. doi: 10.1038/364532a0.
43. Osei-Hyiaman, D., DePetrillo, M., Pacher, P., Liu, J., Radaeva, S., Batkai, S., et al. (2005). Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity. J. Clin. Invest. 115, 1298-1305. doi: 10.1172/JCI200523057.
44. Pi-Sunyer, F. X., Aronne, L. J., Heshmati, H. M., Devin, J., and Rosenstock, J. (2006). Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 295, 761-775. doi: 10.1001/jama.295.7.761.
45. Piazza, P. V., Lafontan, M., and Girard, J. (2007). Integrated physiology and pathophysiology of CB1-mediated effects of the endocannabinoid system. Diabetes Metab. 33, 97-107. doi: 10.1016/j.diabet.2007.02.002.
46. Piscitelli, F., Carta, G., Bisogno, T., Murru, E., Cordeddu, L., Berge, K., et al. (2011). Effect of dietary krill oil supplementation on the endocannabinoidome of metabolically relevant tissues from high-fat-fed mice. Nutr. Metab. (Lond.) 8:51. doi: 10.1186/1743-7075-8-51.
47. Ravinet Trillou, C., Arnone, M., Delgorge, C., Gonalons, N., Keane, P., Maffrand, J. P., et al. (2003). Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol. Regul. Integr. Comp. Physiol. 284, R345-R353. doi: 10.1152/ajpregu.00545.2002.
48. Rolli-Derkinderen, M., Machavoine, F., Baraban, J. M., Grolleau, A., Beretta, L., and Dy, M. (2003). ERK and p38 inhibit the expression of 4E-BP1 repressor of translation through induction of Egr-1. J. Biol. Chem. 278, 18859-18867. doi: 10.1074/jbc.M211696200.
49. Sheskin, T., Hanus, L., Slager, J., Vogel, Z., and Mechoulam, R. (1997). Structural requirements for binding of anandamide-type compounds to the brain cannabinoid receptor. J. Med. Chem. 40, 659-667. doi: 10.1021/jm960752x.
50. Soderstrom, K., Tian, Q., Valenti, M., and Di Marzo, V. (2004). Endocannabinoids link feeding state and auditory perception-related gene expression. J. Neurosci. 24, 10013-10021. doi: 10.1523/JNEUROSCI.3298-04.2004.
51. Takekoshi, K., Fukuhara, M., Quin, Z., Nissato, S., Isobe, K., Kawakami, Y., et al. (2006). Long-term exercise stimulates adenosine monophosphate-activated protein kinase activity and subunit expression in rat visceral adipose tissue and liver. Metab. Clin. Exp. 55, 1122-1128. doi: 10.1016/j.metabol.2006.04.007.
52. Tsang, V. C., Brand, J. A., and Boyer, A. E. (1989). An enzyme-linked immunoelectrotransfer blot assay and glycoprotein antigens for diagnosing human cysticercosis (Taenia solium). J. Infect. Dis. 159, 50-59. doi: 10.1093/infdis/159.1.50.
53. Valenti, M., Cottone, E., Martinez, R., De Pedro, N., Rubio, M., Viveros, M. P., et al. (2005). The endocannabinoid system in the brain of Carassius auratus and its possible role in the control of food intake. J. Neurochem. 95, 662-672. doi: 10.1111/j.1471-4159.2005.03406.x.
54. Watanabe, S., Doshi, M., and Hamazaki, T. (2003). n-3 Polyunsaturated fatty acid (PUFA) deficiency elevates and n-3 PUFA enrichment reduces brain 2-arachidonoylglycerol level in mice. Prostaglandins Leukot. Essent. Fatty Acids 69, 51-59. doi: 10.1016/S0952-3278(03)00056-5.
55. Watkins, B. A., Li, Y., Allen, K. G., Hoffmann, W. E., and Seifert, M. F. (2000). Dietary ratio of (n-6)/(n-3) polyunsaturated fatty acids alters the fatty acid composition of bone compartments and biomarkers of bone formation in rats. J. Nutr. 130, 2274-2284.
56. Watkins, B. A., Li, Y., Lippman, H. E., and Feng, S. (2003). Modulatory effect of omega-3 polyunsaturated fatty acids on osteoblast function and bone metabolism. Prostaglandins Leukot. Essent. Fatty Acids 68, 387-398. doi: 10.1016/S0952-3278(03)00063-2.
57. Watkins, B. A., Li, Y., and Seifert, M. F. (2006). Dietary ratio of n-6/n-3 PUFAs and docosahexaenoic acid: actions on bone mineral and serum biomarkers in ovariectomized rats. J. Nutr. Biochem. 17, 282-289. doi: 10.1016/j.jnutbio.2005.05.012.
58. Weyman, C. M., and Wolfman, A. (1998). Mitogen-activated protein kinase kinase (MEK) activity is required for inhibition of skeletal muscle differentiation by insulin-like growth factor 1 or fibroblast growth factor 2. Endocrinology 139, 1794-1800.
59. Wright, W. E., Sassoon, D. A., and Lin, V. K. (1989). Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56, 607-617. doi: 10.1016/0092-8674(89)90583-7.
60. Zetser, A., Gredinger, E., and Bengal, E. (1999). p38 mitogen-activated protein kinase pathway promotes skeletal muscle differentiation. Participation of the Mef2c transcription factor. J. Biol. Chem. 274, 5193-5200. doi: 10.1074/jbc.274.8.5193.
61. Zhang, W., Thompson, B. J., Hietakangas, V., and Cohen, S. M. (2011). MAPK/ERK signaling regulates insulin sensitivity to control glucose metabolism in Drosophila. PLoS Genet. 7:e1002429. doi: 10.1371/journal.pgen.1002429.